EFIKASI TERAPI BONE MARROW MESENCHYMAL STEM CELL TERHADAP INFEKSI VIRUS HEPATITIS SYSTEMATIC REVIEW

Inggit Dana Ayu Wilujeng, . (2020) EFIKASI TERAPI BONE MARROW MESENCHYMAL STEM CELL TERHADAP INFEKSI VIRUS HEPATITIS SYSTEMATIC REVIEW. Skripsi thesis, Universitas Pembangunan Nasional Veteran Jakarta.

[img] Text
ABSTRAK.pdf

Download (15kB)
[img] Text
AWAL.pdf

Download (771kB)
[img] Text
BAB 1.pdf

Download (132kB)
[img] Text
BAB 2.pdf
Restricted to Repository UPNVJ Only

Download (367kB)
[img] Text
BAB 3.pdf
Restricted to Repository UPNVJ Only

Download (240kB)
[img] Text
BAB 4.pdf
Restricted to Repository UPNVJ Only

Download (520kB)
[img] Text
BAB 5.pdf

Download (120kB)
[img] Text
DAFTAR PUSTAKA.pdf

Download (231kB)
[img] Text
RIWAYAT HIDUP.pdf
Restricted to Repository UPNVJ Only

Download (142kB)
[img] Text
LAMPIRAN.pdf
Restricted to Repository UPNVJ Only

Download (682kB)
[img] Text
ARTIKEL KI.pdf
Restricted to Repository staff only

Download (551kB)

Abstract

The hepatitis B virus has infected 2 billion people and about 170 million people are infected with the hepatitis C virus in the world (Kemkes RI, 2014). Although treatment for hepatitis is available, there is hardly an effective drug to restore tissue in the liver that has been injured. Liver transplantation is the most effective treatment for end-stage liver fibrosis. It is effective to restore liver function and improve liver regeneration, but in in-vitro testing it appears that hepatocytes easily decrease to loss of viability. This review aims to find out the efficacy of bone marrow mesenchymal stem cell therapy against hepatitis virus infection. The design of this study is a literature study in the form of a systematic review with the PRISMA method and screening results obtained in 7 journals. Sampling was done based on inclusion and exclusion criteria. Results showed that BM-MSC can restore liver function, judging by the parameters of liver function values, indicating a better prognosis (MELD scores and others) Giving a high dose of 5 x 10^7 cells, did not give serious side effects or toxicity. More research on the efficacy of BM-MSC therapy against hepatitis virus infection still needs to be done.

Item Type: Thesis (Skripsi)
Additional Information: [No.Panggil : 1710211012] [Pembimbing: Andri Pramesyanti Pramono,] [Penguji 1: Yanto Sandy Tjang,]
Uncontrolled Keywords: Hepatitis Virus, Mesenchymal Bone Marrow Stem Cells, Bone Marrow Stromal Cells, Bone Marrow Stromal Cells, Bone Marrow Cell Transplantation.
Subjects: R Medicine > R Medicine (General)
R Medicine > RC Internal medicine
R Medicine > RM Therapeutics. Pharmacology
Divisions: Fakultas Kedokteran > Program Studi Kedokteran (S1)
Depositing User: Inggit Dana Ayu Wilujeng
Date Deposited: 12 Mar 2021 08:27
Last Modified: 19 Mar 2021 07:28
URI: http://repository.upnvj.ac.id/id/eprint/9155

Actions (login required)

View Item View Item